Isoray, Inc. Business Finance Contracts & Agreements
62 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Escrow Agreements (2)
- Investment Agreements (2)
- Loan Agreements (3)
- Modification Agreements (2)
- Note Agreements (2)
- Purchase Agreements (9)
- Registration Rights Agreements (5)
- Release Agreements (1)
- Security Agreements (1)
- Share Agreements (2)
- Shareholders Agreements (1)
- Stock Agreements (20)
- Underwriting Agreements (5)
- Warrant Agreements (6)
- Amendment No. 1 to Asset Purchase Agreement, dated March 28, 2024, by and among Isoray Medical, Inc., GT Medical Technologies, Inc., and Perspective Therapeutics, Inc (Filed With SEC on April 3, 2024)
- Registration Rights Agreement, dated January 22, 2024, by and between the Company and Lantheus Alpha Therapy, LLC (Filed With SEC on March 28, 2024)
- Registration Rights Agreement, dated March 6, 2024 (Filed With SEC on March 6, 2024)
- Investment Agreement, dated March 4, 2024 (Filed With SEC on March 6, 2024)
- Form of Pre-funded Warrant to Purchase Common Stock (Filed With SEC on January 22, 2024)
- Asset Purchase Agreement, dated as of January 8, 2024, by and among Perspective Therapeutics, Inc. and Progenics Pharmaceuticals, Inc (Filed With SEC on January 17, 2024)
- Investment Agreement, dated as of January 8, 2024, by and among Perspective Therapeutics, Inc. and Lantheus Alpha Therapy, LLC (Filed With SEC on January 17, 2024)
- Asset Purchase Agreement, dated December 7, 2023, by and among Isoray Medical, Inc., GT Medical Technologies, Inc., and Perspective Therapeutics, Inc (Filed With SEC on December 12, 2023)
- Promissory Note between Viewpoint Molecular Targeting, Inc.and Hills Bank and Trust Company, dated December 29, 2022 (Filed With SEC on May 15, 2023)
- Commercial Real Estate Purchase Agreementbetween Viewpoint Molecular Targeting, Inc.and PMP Properties, LLC, dated August 16, 2022, as amended (Filed With SEC on May 15, 2023)
- Form of Registration Rights and Lock-Up Agreement dated as of January 31, 2023 (Filed With SEC on February 6, 2023)
- 2023Supply Contract, executed December 12, 2022, between Isoray Medical, Inc., and Joint Stock Company Isotope (confidential portions of the exhibit have been omitted) (Filed With SEC on December 14, 2022)
- Promissory Note and Security Agreement, dated November 22, 2022, between Isoray, Inc. and Viewpoint Molecular Targeting, Inc (Filed With SEC on November 29, 2022)
- Addendum No. 6 to Supply Contract, dated May 5, 2022, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on May 13, 2022)
- Addendum No. 5 to Supply Contract, dated May 4, 2022, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on May 13, 2022)
- Addendum No. 4 to Supply Contract, dated April 11, 2022, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on April 15, 2022)
- Addendum No. 3 to Supply Contract, dated April 11, 2022, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on April 15, 2022)
- Addendum No. 2 to Supply Contract, dated August 19, 2021, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on August 25, 2021)
- Addendum No. 1 to Supply Contract, dated July 29, 2021, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on August 3, 2021)
- Supply Contract, dated March 18, 2021, between Isoray Medical, Inc., and Joint Stock Company Isotope (confidential portions of the exhibit have been omitted) (Filed With SEC on March 23, 2021)
- Addendum No. 1 to Supply Contract, dated February 10, 2021, by and between Isoray Medical, Inc. and Joint Stock Company (Filed With SEC on February 12, 2021)
- Underwriting Agreement between Isoray, Inc. and Oppenheimer & Co. Inc., dated February 4, 2021 (Filed With SEC on February 4, 2021)
- Underwriting Agreement between Isoray, Inc. and Oppenheimer & Co. Inc., dated October 20, 2020 (Filed With SEC on October 22, 2020)
- Addendum No. 2, dated August 14, 2020, to the Supply Contract dated July 30, 2019, between Isoray Medical, Inc., and Joint Stock Company Isotope (confidential portions of the... (Filed With SEC on September 25, 2020)
- Addendum No. 1, dated August 5, 2019, to the Supply Contract dated July 30, 2019, between Isoray Medical, Inc., and Joint Stock Company Isotope (Filed With SEC on September 25, 2020)
- Supply Contract, dated August 26, 2020, between Isoray Medical, Inc., and Joint Stock Company Isotope (confidential portions of the exhibit have been omitted) (Filed With SEC on August 31, 2020)
- Equity Distribution Agreement between Isoray, Inc. and Oppenheimer & Co. Inc., dated March 31, 2020 (Filed With SEC on April 6, 2020)
- Contract Modification, entered into on August 19, 2019 with an effective date of July 3, 2019, to Contract No. X-40403 between Energy Northwest and Isoray Medical, Inc (Filed With SEC on September 27, 2019)
- Amendment, dated July 9, 2018, to the Share Rights Agreement, dated as of February 1, 2007, between IsoRay, Inc. and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on July 12, 2018)
- Form of Warrant (Filed With SEC on July 11, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on July 11, 2018)
- IsoRay, Inc. Stock Option Agreement and Notice of Grant of Stock Option to Lori A. Woods, dated June 13, 2018 (Filed With SEC on June 19, 2018)
- Warrant to Purchase Common Stock, dated May 20, 2018 (Filed With SEC on May 21, 2018)
- Warrant to Purchase Common Stock, dated October 3, 2017 (Filed With SEC on October 10, 2017)
- RESCISSION AND RELEASE AGREEMENT Port of Benton-IsoRay Medical, Inc. (Filed With SEC on June 8, 2017)
- CONTRACT MODIFICATION (Filed With SEC on February 9, 2017)
- AMENDMENT TO SHARE RIGHTSAGREEMENT (Filed With SEC on February 3, 2017)
- ISORAY, INC. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on February 19, 2016)
- REAL ESTATE PURCHASE AND SALE AGREEMENT (Filed With SEC on September 14, 2015)
- ISORAY, INC. 2014 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on May 15, 2014)